| Title |
How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? - A Statistical Analysis of the ClinicalTrials.gov Database
|
|---|---|
| Published in |
PLOS ONE, July 2014
|
| DOI | 10.1371/journal.pone.0101826 |
| Pubmed ID | |
| Authors |
Hiroki Saito, Christopher J. Gill |
| Abstract |
Achieving transparency in clinical trials, through either publishing results in a journal or posting results to the ClinicalTrials.gov (CTG) web site, is an essential public health good. However, it remains unknown what proportion of completed studies achieve public disclosure of results (PDOR), or what factors explain these differences. |
X Demographics
The data shown below were collected from the profiles of 94 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 23 | 24% |
| United States | 18 | 19% |
| Belgium | 3 | 3% |
| Canada | 3 | 3% |
| Netherlands | 2 | 2% |
| Sweden | 2 | 2% |
| Australia | 2 | 2% |
| Italy | 2 | 2% |
| Switzerland | 1 | 1% |
| Other | 5 | 5% |
| Unknown | 33 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 63 | 67% |
| Scientists | 18 | 19% |
| Practitioners (doctors, other healthcare professionals) | 8 | 9% |
| Science communicators (journalists, bloggers, editors) | 5 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 5% |
| New Zealand | 1 | 2% |
| Unknown | 53 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 28% |
| Student > Master | 9 | 16% |
| Student > Ph. D. Student | 7 | 12% |
| Professor | 4 | 7% |
| Other | 4 | 7% |
| Other | 10 | 18% |
| Unknown | 7 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 28% |
| Economics, Econometrics and Finance | 5 | 9% |
| Business, Management and Accounting | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Engineering | 3 | 5% |
| Other | 13 | 23% |
| Unknown | 14 | 25% |